Evidence map›Paper›PMID 30899479›Full record

ArticleClinical case reports2019

Metastatic mixed adenoneuroendocrine carcinoma of the liver successfully resected by hepatic trisectionectomy following chemotherapy: A case report.

Osamu Sato, Takahiro Tsuchikawa, Toru Yamada, Daisuke Sato, Yoshitsugu Nakanishi, Toshimichi Asano, Takehiro Noji, Kurashima Yo, Yuma Ebihara, Soichi Murakami and 5 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Osamu SatoDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.ORCID 0000-0002-0903-1650
Takahiro TsuchikawaDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Toru YamadaDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Daisuke SatoDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Yoshitsugu NakanishiDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Toshimichi AsanoDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Takehiro NojiDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Kurashima YoDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Yuma EbiharaDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Soichi MurakamiDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Toru NakamuraDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Keisuke OkamuraDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Toshiaki ShichinoheDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Tomoko MitsuhashiDepartment of Surgical Pathology Hokkaido University Hospital Sapporo Japan.
Satoshi HiranoDepartment of Gastroenterological Surgery II Hokkaido University Faculty of Medicine Sapporo Japan.
Hokkaido University · JPHokkaido University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chemotherapy guidelines for mixed adenoneuroendocrine carcinoma (MANEC) remain poorly defined, and prognosis remains dismal. In this case, we successfully performed resection after FOLFOX for unresectable metastatic MANEC of the liver. Thus, chemotherapy for adenocarcinoma may be effective for MANEC.

Indexed as

immunohistochemistrymixed adenoneuroendocrine carcinomaneuroendocrine carcinomaneuroendocrine tumor

Identifiers

PMID30899479
PMCPMC6406150
OpenAlexW2912250820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.